Mylan Pharmaceuticals Inc recalls Carton label
- Published
- 9 Sept 2026
- Units affected
- 11,336 units
- Agency
- FDA
- Country
- United States
The hazard
Failed Dissolution Specifications
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Carton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505, Made in India, NDC 67457-386-81. Vial Label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, Single Dose Vial, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505, Made in India, NDC 67457-386-00.
- Brand / company
- Mylan Pharmaceuticals Inc
- Codes / lots
- Lot: 3242616, Exp. April 2027; 8220216, Exp. Nov 2027
- Distribution
- U.S. Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 9 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.